BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21775269)

  • 1. Update on the diagnosis of cancer of unknown primary (CUP) origin.
    Ariza A; Balañá C; Concha Á; Hitt R; Homet B; Matilla A; Alba E
    Clin Transl Oncol; 2011 Jul; 13(7):434-41. PubMed ID: 21775269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer of unknown primary site: 20 questions to be answered.
    Pavlidis N; Pentheroudakis G
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii303-7. PubMed ID: 20943633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular diagnosis of the tissue of origin in cancer of unknown primary site: useful in patient management.
    Greco FA
    Curr Treat Options Oncol; 2013 Dec; 14(4):634-42. PubMed ID: 23990214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of pathology in the diagnostics of CUP syndrome].
    Stenzinger A; Kriegsmann M; Weichert W
    Radiologe; 2014 Feb; 54(2):124-33. PubMed ID: 24463713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic work-up of carcinoma of unknown primary: from immunohistochemistry to molecular profiling.
    Oien KA; Dennis JL
    Ann Oncol; 2012 Sep; 23 Suppl 10():x271-7. PubMed ID: 22987975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptions of cancer of unknown primary site: a national survey of Australian medical oncologists.
    Karapetis CS; Guccione L; Tattersall MH; Gooden H; Vajdic CM; Lambert S; Robotin M; Mileshkin L; Schofield P
    Intern Med J; 2017 Apr; 47(4):408-414. PubMed ID: 28101916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer of unknown primary sites: what radiologists need to know and what oncologists want to know.
    Kim KW; Krajewski KM; Jagannathan JP; Nishino M; Shinagare AB; Hornick JL; Ramaiya NH
    AJR Am J Roentgenol; 2013 Mar; 200(3):484-92. PubMed ID: 23436835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid biopsy: a new diagnostic, predictive and prognostic window in cancers of unknown primary.
    El Rassy E; Khaled H; Pavlidis N
    Eur J Cancer; 2018 Dec; 105():28-32. PubMed ID: 30388661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review on Cancer of Unknown Primary Origin: The Role of Molecular Biomarkers in the Identification of Unknown Primary Origin.
    Yan N; Zhang Y; Guo X; Yuan D; Tian G; Yang J
    Methods Mol Biol; 2020; 2204():109-119. PubMed ID: 32710319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinomas of an unknown primary origin--diagnosis and treatment.
    Massard C; Loriot Y; Fizazi K
    Nat Rev Clin Oncol; 2011 Nov; 8(12):701-10. PubMed ID: 22048624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of care.
    Hainsworth JD; Greco FA
    Virchows Arch; 2014 Apr; 464(4):393-402. PubMed ID: 24487792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and therapeutic management of cancer of an unknown primary.
    Pavlidis N; Briasoulis E; Hainsworth J; Greco FA
    Eur J Cancer; 2003 Sep; 39(14):1990-2005. PubMed ID: 12957453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Structured diagnostics and therapy of the CUP syndrome].
    Löffler H; Neben K; Krämer A
    Radiologe; 2014 Feb; 54(2):112-6. PubMed ID: 24435157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoma of unknown primary with a colon-cancer profile-changing paradigm and emerging definitions.
    Varadhachary GR; Raber MN; Matamoros A; Abbruzzese JL
    Lancet Oncol; 2008 Jun; 9(6):596-9. PubMed ID: 18510991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in refining the clinical management of cancer of unknown primary in the molecular era.
    Rassy E; Pavlidis N
    Nat Rev Clin Oncol; 2020 Sep; 17(9):541-554. PubMed ID: 32350398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic carcinoma of unknown primary: diagnostic approach using immunohistochemistry.
    Conner JR; Hornick JL
    Adv Anat Pathol; 2015 May; 22(3):149-67. PubMed ID: 25844674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New strategies for carcinoma of unknown primary: the role of tissue-of-origin molecular profiling.
    Varadhachary G
    Clin Cancer Res; 2013 Aug; 19(15):4027-33. PubMed ID: 23519898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer of Unknown Primary origin in the genomic era: Elucidating the dark box of cancer.
    Economopoulou P; Mountzios G; Pavlidis N; Pentheroudakis G
    Cancer Treat Rev; 2015 Jul; 41(7):598-604. PubMed ID: 26033502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoma of unknown primary (CUP): an update for histopathologists.
    Beauchamp K; Moran B; O'Brien T; Brennan D; Crown J; Sheahan K; Cotter MB
    Cancer Metastasis Rev; 2023 Dec; 42(4):1189-1200. PubMed ID: 37394540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic challenges of patients with carcinoma of unknown primary.
    Rassy E; Pavlidis N
    Expert Rev Anticancer Ther; 2020 Sep; 20(9):775-783. PubMed ID: 32779501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.